Home     About Us     Team     Products     News     Contact     FAQ     Account

CD52 Monoclonal Antibodies

Campath (alemtuzumab)

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada. It is also used in some conditioning regimens for bone marrow transplantation, kidney transplantation and islet cell transplantation....Wikipedia

 

 

Manufacturer's Website: Not Available                                                                                                                                      Average retail cost: $1,900/vial

Lemtrada (alemtuzumab)

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada. It is also used in some conditioning regimens for bone marrow transplantation, kidney transplantation and islet cell transplantation....Wikipedia

 

 

Manufacturer's Website: Lemtrada                                                                                                                                                Average retail cost: $22,200/vial

Copyright 2006-2020 Automated Clinical Guidelines, LLC. All rights reserved.